NIH Offers $5M for Biomarker Studies of Alzheimer's Progression in Down Syndrome | GenomeWeb

NEW YORK (GenomeWeb) – The National Institutes of Health will award up to $5 million next fiscal year to fund one or two research teams that will use a range of biomarker typesto identify the progression of Alzheimer's disease in adults who have Down syndrome.

Adults with Down syndrome are at "extremely high risk" of developing AD, NIH said in a funding announcement on Friday. These projects will seek to characterize the longitudinal trajectory of AD-related genetic, biochemical, imaging, clinical, and cognitive biomarkers in adults with Down syndrome.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.